Yawei Xu
- Pharmacology top 10%
-
- Coronary Interventions and Diagnostics 5
-
- Acute Myocardial Infarction Research 4
- Cardiac electrophysiology and arrhythmias 3
- Cardiac Arrhythmias and Treatments 2
- Atrial Fibrillation Management and Outcomes 2
- Cardiovascular Disease and Adiposity 1
-
- Cardiac Imaging and Diagnostics 2
-
- Cardiac Ischemia and Reperfusion 2
- Co-authors
- S BachowskiEarl F. WalborgD.E. StevensonJeffrey S. IsenbergKyle L. KolajaJames E. KlaunigHongwei WangHuajin Liu
- Journals
- Scientific Reports (1 paper)Environmental Health Perspectives (1 paper)Free Radical Biology and Medicine (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yawei Xu
18 papers receiving 589 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 113
- Biochemistry 38
- Pharmacology 48
- Health, Toxicology and Mutagenesis 71
- Toxicology 14
Countries citing papers authored by Yawei Xu
This map shows the geographic impact of Yawei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Xu more than expected).
Fields of papers citing papers by Yawei Xu
This network shows the impact of papers produced by Yawei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Xu. The network helps show where Yawei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yawei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2022 | 14 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 11 | |
| 8 | 2019 | 21 | |
| 9 | 2018 | 22 | |
| 10 | 2018 | 41 | |
| 11 | High Serum Level of Secreted Frizzled-Related Protein 5 (sfrp5) is Associated with Future Cardiovascular Events | 2017 | 6 |
| 12 | 2015 | 25 | |
| 13 | 2013 | 28 | |
| 14 | Comparison of paclitaxal vs. sirolimus eluting stents with bio-degradable polymer for the treatment of coronary bifurcation lesions: subgroup analysis from DKCRUSH-I and DKCRUSH-II studies. | 2012 | 4 |
| 15 | Coronary bifurcation angle from 3-D predicts clinical outcomes after stenting bifurcation lesions. | 2012 | 2 |
| 16 | [A meta-analysis of early percutaneous coronary intervention within 24 hours of thrombolysis in acute ST-elevation myocardial infarction]. | 2011 | 2 |
| 17 | Feasibility of using 6F angiographic catheters for primary percutaneous coronary intervention in patients with acute myocardial infarction. | 2010 | 1 |
| 18 | Different edge effects of paclitaxel- and sirolimus-eluting stents on proximal and distal edges in patients with unstable angina: serial intravascular ultrasound analysis. | 2009 | 1 |
| 19 | 1998 | 429 | |
| 20 | Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction complicated with cardiogenic shock. | 1996 | 1 |
About Yawei Xu
Yawei Xu is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Biochemistry, having authored 20 papers that have together received 615 indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (5 papers), Acute Myocardial Infarction Research (4 papers), Cardiac electrophysiology and arrhythmias (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Cardiac Imaging and Diagnostics (2 papers), Cardiac Ischemia and Reperfusion (2 papers) and Cardiovascular Disease and Adiposity (1 paper). The work is most often cited by research in Cancer Research (113 citations), Biochemistry (38 citations) and Pharmacology (48 citations). Yawei Xu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include S Bachowski, Earl F. Walborg, D.E. Stevenson, Jeffrey S. Isenberg, Kyle L. Kolaja, James E. Klaunig, Hongwei Wang, Huajin Liu, Hua Cao and Zengyong Qiao. Their work appears in journals such as Scientific Reports, Environmental Health Perspectives and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.